跳到主要內容

臺灣博碩士論文加值系統

(216.73.216.181) 您好!臺灣時間:2025/12/14 08:49
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

: 
twitterline
研究生:陳育麟
研究生(外文):Yu-Lin Chen
論文名稱:有運動高血壓者之動脈硬化度、交感迷走神經活性及危險因子特性
論文名稱(外文):Comparison of arterial stiffness, vagosympathetic activity and risk factors in subjects with exercise hypertension and normotension
指導教授:蔡美文蔡美文引用關係
指導教授(外文):Mei-Wun Tsai
學位類別:碩士
校院名稱:國立陽明大學
系所名稱:物理治療學系暨研究所
學門:醫藥衛生學門
學類:復健醫學學類
論文種類:學術論文
論文出版年:2006
畢業學年度:94
語文別:中文
論文頁數:95
中文關鍵詞:運動高血壓動脈硬化度交感迷走神經活性心血管危險因子
外文關鍵詞:exercise hypertensionarterial stiffnessvagosympathetic activitycardiovascular risk factor
相關次數:
  • 被引用被引用:3
  • 點閱點閱:585
  • 評分評分:
  • 下載下載:109
  • 收藏至我的研究室書目清單書目收藏:1
背景與目的:高血壓已被證實與心血管疾病有持續的相關性,而動脈硬化及自律神經失調被認為是引起高血壓之重要危險因子。近年有研究指出有一些人休息血壓正常,但於劇烈運動時血壓則急促地增加,而有運動高血壓的現象,有研究認為運動高血壓為日後高血壓之早期警訊,但其與休息高血壓之致病機轉是否一致至今仍尚未明瞭。本研究目的為比較運動高血壓、休息高血壓與正常血壓者之交感迷走神經活性、動脈硬化指數及相關危險因子的異同。方法:本研究為橫斷式相關性研究,納入65位男性受測者,平均年齡為50.6±6.5歲,平時血壓皆低於160/100 mmHg及尚未開始接受藥物控制,也沒有罹患心血管疾病或腦血管病變、糖尿病、周邊血管病變或有服用影響自律神經表現之藥物及有任何進行運動測試之禁忌者。本研究測量主要包含:動脈硬化檢測(臂踝動脈波速﹔baPWV)、休息及壓力刺激下之心率變異度、次大運動測試及心血管相關危險因子問卷調查,並依臨床定義將受測者分為無休息高血壓組(n=55)及高血壓組(休息血壓≧140/90 mmHg者,n=10),或分為無運動高血壓組(n=25)及運動高血壓組(次大運動測試時之運動最大收縮壓≧200 mmHg者,n=40),另亦合併休息及運動血壓反應分為血壓正常組(n=25)、無休息高血壓而有運動高血壓組(n=30)、及有休息及運動高血壓組(n=10)。利用獨立樣本t檢定(independent-samples t test)、單因子變異數分析(one-way analysis of variance)、卡方檢定、逐步複迴歸(stepwise multiple regression)及邏輯性迴歸(logistic regression)等進行資料統計分析,顯著程度皆訂於0.05。結果:55位休息血壓正常者中有30位(54.5%)出現運動高血壓,而10位有休息高血壓者也都合併有運動高血壓。比較有無休息高血壓的異同發現,高血壓組有50%的受測者有高血壓家族史且有80%為高鹽飲食,baPWV為1616.6±250.5 cm/s,明顯高於無高血壓組(p<0.05)。有運動高血壓者之心血管危險因子分數4.7±1.6分、單位運動量之收縮壓變化斜率為17.9±7.5 mmHg/MET、baPWV為1538.4±215.2 cm/s,及baPWV的異常比例(70%)皆明顯高於無運動高血壓組(p<0.05)。合併休息及運動高血壓發現在”有休息及運動高血壓”組之高血壓家族史比例、高鹽飲食比例、心血管危險因子分數、單位運動量之收縮壓變化率及baPWV皆明顯高於僅運動高血壓組及血壓正常組(p<0.05)。由逐步複迴歸分析發現baPWV、心血管危險因子分數及高血壓家族史對休息收縮壓有顯著影響,解釋力(調整後R2)為43%﹔對運動收縮壓有顯著影響的因子為心血管危險因子分數、baPWV及壓力-休息之LF%,解釋力(調整後R2)為32%。以邏輯性迴歸分析發現,有高血壓家族史者及baPWV較高者發生休息高血壓的危險性分別為11.4(95%CI 1.9-68.8)及1.005(95%CI 1.001-1.010),可解釋有無休息高血壓之35%的總變異性,心血管危險因子分數及baPWV較高者與壓力-休息之RR mean較低者則發生運動高血壓的危險性分別為1.7(95%CI 1.2-2.6)、1.004(95%CI 1.001-1.008)及0.991(95%CI 0.98-0.999),可解釋有無運動高血壓之41%的總變異性。結論:休息血壓正常者仍有相當高比例的人會發生運動高血壓,而本研究發現運動高血壓和休息高血壓都與心血管危險因子分數及動脈硬化度有顯著相關性,但高血壓家族史對休息高血壓的發生影響較大,休息及壓力刺激之心率變異度的自主神經功能反應則對運動高血壓的發生較有影響,顯示運動高血壓與休息高血壓間仍有不盡相同的機轉特性,結果有助於增進瞭解運動高血壓的臨床意義,並可作為納入早期健康篩檢防治項目的參考。
Background and purpose : Hypertension is a prevalent worldwide problem. Besides the major risk factors, arterial stiffness and autonomic nervous system (ANS) dysfunction have also important roles on the pathophysiology of hypertension. Exercise hypertension, an exaggerated rising of blood pressure (BP) during physical activity, has been found to be a strong predictor of cardiovascular mortality and may be an early marker of essential hypertension. However, the exact mechanism of exercise hypertension is unclear. The purpose of this study was to compare the differences of arterial stiffness, vagosympathetic activity and risk factors in subjects with exercise hypertension, resting hypertension and normotension. Methods : This was an exploratory cross-sectional study. Sixty-five men (50.6±6.5 years old) with resting BP below 160/100 mmHg were included. Those who had the history of chronic diseases, exercise contraindications and taking any medicines affecting BP or ANS were excluded. All subjects received noninvasive arterial stiffness test, submaximal exercise test, heart rate variability test (HRV) at rest and under mental stress, and were interviewed the related risk factors by questionnaires. All subjects were grouped as resting hypertension (BP≧140/90mmHg, n=10), or not (BP<140/90mmHg, n=55), exercise hypertension (SBP≧200mmHg, n=40), or not (SBP<200mmHg, n=25), and also grouped into normotension (n=25), only exercise hypertension (n=30), or both resting and exercise hypertension (n=10). Results : Thirty of fifty-five subjects (54.5%) with normal resting BP appeared exercise hypertension, while all subjects with resting hypertension had exercise hypertension. Subjects in the resting hypertension group had higher proportion of having hypertensive family history and high-sodium diet, and higher brachial-ankle pulse wave velocity (baPWV) compared to those without resting hypertension (p<0.05). Subjects with exercise hypertension had higher cardiovascular risk factor score, exercise SBP slope, and baPWV compared to those without exercise hypertension (p<0.05). Subjects with both resting and exercise hypertension had higher proportion of hypertensive family history, high-sodium diet, the cardiovascular risk factor score, exercise SBP slope and baPWV than those with only exercise hypertension or normotension. In the results of multiple regression, the higher resting SBP were association with having hypertensive family history and the higher baPWV and cardiovascular risk factor score (adjusted R2=43%). Exercise SBP was significantly associated with cardiovascular risk factor score, baPWV and the change of HRV in normalized low frequency power (LF%) under mental stress and at rest (adjusted R2=32%). In logistic regression, subjects with higher baPWV (OR:1.005, 95%CI:1.001-1.010) and having of hypertension family history (OR:11.4, 95%CI:1.9-68.8) had higher risk to have resting hypertension (adjusted R2=35%). Subjects with exercise hypertension had higher cardiovascular risk factor score (OR:1.7, 95%CI:1.2-2.6), baPWV (OR:1.004, 95%CI:1.001-1.008), and lower change of HRV in the mean of R-R intervals under mental stress and at rest (OR:0.991, 95%CI:0.98-0.999), R2=41%. Conclusion : High prevalence of exercise hypertension could be found in the middle-aged men with normal resting BP. Cardiovascular risk factor score and baPWV were associated with both resting and exercise hypertension. Hypertensive family history was a major risk factor of resting hypertension, but heart rate variability at rest and under mental stress affected exercise hypertension more. Therefore, exercise hypertension may be an early sign of resting hypertension but some different underlying mechanisms may exist between both hypertension. Our results may highlight the clinical significance of exercise hypertension in the early health screening program.
目錄..............Ι
表目錄............Ⅳ
圖目錄............Ⅵ
附錄..............Ⅶ
摘要..............Ⅷ
Abstract..........Ⅹ

第一章 緒論...............................................1
第一節 研究背景.........................................1
第二節 研究目的.........................................4
第三節 研究假說.........................................4
第四節 研究重要性.......................................5
第二章 文獻回顧...........................................6
第一節 高血壓...........................................6
1-1 休息血壓...........................................6
1-2 運動血壓...........................................8
第二節 動脈硬化與血壓的關係............................11
第三節 心率變異度與血壓的關係..........................14
第三章 研究方法..........................................18
第一節 研究設計........................................18
第二節 研究對象........................................18
第三節 測量工具與方法..................................19
3-1 休息血壓..........................................19
3-2 運動血壓..........................................19
3-3 臂踝動脈波速度....................................20
3-4 心率變異度........................................21
3-5 中國人健康問卷....................................22
3-6 七日回顧活動量問卷................................23
3-7 其他相關資料的收集................................24
第四節 研究步驟........................................25
第五節 資料處理與統計分析..............................26
第四章 結果..............................................28
第一節 研究對象........................................28
第二節 有無休息高血壓者之交感迷走神經活性、動脈硬化及危險
因子的特性......................................29
第三節 有無運動高血壓者之交感迷走神經活性、動脈硬化及危險
因子的特性......................................31
第四節 合併有休息及運動高血壓者、無休息高血壓但有運動高血
壓者與血壓正常者彼此間之交感迷走神經活性、動脈硬化
及危險因子的特性................................32
第五節 休息血壓及運動血壓之相關因素的探討..............33
第五章 討論..............................................35
第一節 運動高血壓的發生比例............................35
第二節 休息高血壓之交感迷走神經活性、動脈硬化及危險因子的
特性............................................37
第三節 運動高血壓之交感迷走神經活性、動脈硬化及危險因子的
特性............................................40
第四節 合併休息及運動高血壓之交感迷走神經活性、動脈硬化
及危險因子的特性................................42
第五節 休息及運動血壓之相關因素........................44
第六節 臨床應用........................................46
第七節 研究限制........................................47
第八節 未來研究建議....................................47
第六章 結論..............................................49
參考文獻..................................................50
1.Levenson JW, Skerrett PJ, Gaziano JM. Reducing the global burden of cardiovascular disease: the role of risk factors. Prev Cardiol 2002; 5:188-99.
2.行政院衛生署衛生統計資訊網
http://www.doh.gov.tw/statistic/index.htm
3.Gibbons GH. Pathobiology of hypertension. In. Topol EJ, editor. Comprehensive cardiovascular medicine. Philadelphia: Lippincott-Raven Publishers, 1998. p.2907-18.
4.行政院衛生署國民健康局,2002年國民健康訪問調查報告,2002。
5.Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA,Izzo JL Jr., Jones DW, Materson BJ, Oparil S, Wright JT Jr., Roccella EJ, National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560–72.
6.行政院衛生署國民健康局,高血壓防治手冊-高血壓偵測、控制與治療流程指引,2004。
7.Daniel W, Hall JE. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and Evidence From New Hypertension Trials. Hypertension 2004;43:1-3.
8.Herkenhoff FL, Lima EG, Goncalves RA, Souza AC, Vasquez EC, Mill JG. Doppler echocardiographic indexes and 24-h ambulatory blood pressure data in sedentary middle-aged men presenting exaggerated blood pressure response during dynamical exercise test. Clin Exp Hypertens 1997; 19:1101-16.
9.Kannel WB. Hypertension and the risk of cardiovascular disease. In: Laragh JH, Brenner BM, editors. Hypertension: Pathophysiology, Diagnosis, and Management. New York: Raven Press; 1990:101-17.
10.Mundal R, Kjeldsen SE, Sandvik L, Erikssen G, Thaulow Erik, Erikssen J. Exercise blood pressure predicts cardiovascular mortality in middle-aged men. Hypertension 1994;24:56-62.
11.Mundal R, Kjeldsen SE, Sandvik L, Erikssen G, Thaulow Erik, Erikssen J. Exercise blood pressure predicts mortality from myocardial infarction. Hypertension 1996;27:324-9.
12.Lim PO, Donnan PT, MacDonald TM. Blood pressure determinants of left ventricular wall thickness and mass index in hypertension: comparing office, ambulatory and exercise blood pressure. J Hum Hypertens 2001; 15:627-33.
13.Kokkinos PF, Andreas PE, Coutoulakis E, Colleran JA, Narayan P, Dotson CO, et al. Determinants of exercise blood pressure response in normotensive and hypertensive women: role of cardiorespiratory fitness. J Cardiopulm Rehabil 2002;22:178-83.
14.Zanettini JO, Fuchs FD, Zanettini MT, Zanettini JP. Is hypertensive response in treadmill testing better identified with correction for working capacity? A study with clinical, echocardiographic and ambulatory blood pressure correlates. Blood Press 2004;13:225-9.
15.Chobanian AV, Hill M. National Heart, Lung, and Blood Institute Workshop on Sodium and Blood Pressure: a critical review of current scientific evidence. Hypertension 2000;35:858-63.
16.Vollmer WM, Sacks FM, Ard J, Appe LJ, Bray GA, Simons-Morton DG, et al. Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-Sodium trial. Ann Intern Med 2001;135:1019-28.
17.Miyai N, Arita M, Miyashita K, Morioka I, Shiraishi T, Nishio I, et al. Antihypertensive effects of aerobic exercise in middle-aged normotensive men with exaggerated blood pressure response to exercise. Hypertens Res 2002;25:507-14.
18.Simon A, Levenson J. Early detection of subclinical atherosclerosis in asymptomatic subjects at high risk for cardiovascular disease. Hypertension 1993;15:1069-76.
19.Oliver JJ, Webb DJ. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 2003;23:554-66.
20.John S, Schmieder RE. Impaired endothelial function in arterial hypertension and hypercholesterolesterolemia: potential mechanisms and differences. J Hypertens 2000;18:363-74.
21.Pumprla J, Howorka K, Groves D, Chester M, Nolan J. Functional assessment of heart rate variability: physiological basis and practical applications. Int J Cardiol 2002;84:1-14.
22.Hayano J, Sakakibara Y, Yamada A, Yamada M, Mukai S, Fujinami T, et al. Accuracy of assessment of cardiac vagal tone by heart rate variability in normal subjects. Am J Cardiol 1991;67:199-204.
23.Kuo CD, Chen GY. Comparison of three recumbent positions on vagal and sympathetic modulation using spectral heart rate variability in patients with coronary artery disease. Am J Cardiol 1998;81:392-6.
24.Polanczyk CA, Rohde LE, Moraes RS, Ferlin EL, Leite C, Ribeiro JP. Sympathetic nervous system representation in time and frequency domain indices of heart rate variability. Eur J Appl Physiol 1998;79:69-73.
25.Piccirillo G, Viola E, Nocco M, Durante M, Tarantini S, Marigliano V. Autonomic modulation of heart rate and blood pressure in normotensive offspring of hypertensive subjects. J Lab Clin Med 2000;135:145-52.
26.Mussalo H, Vanninen E, Ikaheimo R, Laitinen T, Laakso M, Lansimies E, et al. Heart rate variability and its determinants in patients with severe or mild essential hypertension. Clin Physiol 2001;21:594-604.
27.Hansson L. The benefits of lowing elevated blood pressure: a critical review of studies of cardiovascular morbidity and mortality in hypertension. J Hypertension. 1996;14:537-44.
28.Chiu YH, Wu SC, Tseng CD, Yen MF, Chen TH. Progression of pre-hypertension, stage 1 and 2 hypertension (JNC 7): a population-based study in Keelung, Taiwan (Keelung Community-based Integrated Screening No. 9). J Hypertens 2006;24:821-28.
29.Kohl HW, Nichaman MZ, Frankowski RF, Blair SN. Maximal exercise hemodynamics and risk of mortality in apparently healthy men and women. Med Sci Sports Exerc 1996;28:601-9.
30.Miyai N, Arita M, Morioka I, Miyashita K, Nishio I, Takeda S. Exercise BP response in subjects with high-normal BP: exaggerated blood pressure response to exercise and risk of future hypertension in subjects with high-normal blood pressure. J Am Coll Cardiol 2000;36:1626-31.
31.Lauer MS, Levy D, Anderson KM, Plehn JF. Is there a relationship between exercise systolic blood pressure response and left ventricular mass? The Framingham Heart Study. Ann Intern Med 1992;116:203-10.
32.Manolio TA, Burke GL, Savage PJ, Sidney S, Gardin JM, Oberman A. Exercise blood pressure response and 5-year risk of elevated blood pressure in a cohort of young adults: the CARDIA study. Am J Hypertens1994;7:234-41.
33.Millar-Craig MW, Balasubramanian V, Mann S, Raftery EB. Use of graded exercise testing in assessing the hypertensive patient. Clin Cardiol 1980;3:236-40.
34.Prud’homme D, Despres JP, Landry JF, Moorjani S, Lupien PJ, Tremblay A, et al. Systolic blood pressure during submaximal exercise : an important correlate of cardiovascular disease risk factors in normotensive obese women. Metabolism 1994;43:18-23.
35.Molineux D, Steptoe A. Exaggerated blood pressure responses to submaximal exercise in normotensive adolescents with a family history of hypertension. J Hypertens 1988;6:361-36.
36.Wilson MF, Sung BH, Pincomb GA, Lovallo WR. Exaggerated pressure response to exercise in men at risk for systemic hypertension. Am J Cardioal 1990;66:731-6.
37.Miyai N, Arita M, Miyashita K, Morioka I, Shiraishi T, Nishio I. Blood pressure response to heart rate during exercise test and risk of future hypertension. Hypertension 2002;39:761-6.
38.Singh JP, Larson MG, Manolio TA, O’Donnell CJ, Lauer M, Evans JC. et al. Blood pressure response during treadmill testing as a risk factor for new-onset hypertension. Circulation 1999;99:1831-6.
39.李宏文、王國哲、賴世偉、劉秋松、陳維恭。脈波進行速度與動脈硬化危險因子相關性之研究。中台灣醫誌 2003;8 Suppl:S29-35。
40.Matsui Y, Kario K, Ishikawa J, Eguchi K, Hoshide S, Shimada K. Reproducibility of arterial stiffness indices (pulse wave velocity and augmentation index) simultaneously assessed by automated pulse wave analysis and their associated risk factors in essential hypertensive patients. Hypertens Res 2004;27:851-7.
41.Safar H, Mourad JJ, Safar M, Blacher J. Aortic pulse wave velocity, an independent maker of cardiovascular risk. Arch Mal Coeur 2002; 95:1215-8.
42.Chuang SY, Chen CH, Cheng CM, Chou P. Combined use of brachial-ankle pulse velocity and ankle-brachial index for fast assessment of arteriosclerosis and atherosclerosis in a community. Int J Cardiol 2005; 98:99-105.
43.Yambe M, Tomiyama H, Hirayama Y, Gulniza Z, Takata Y, Koji Y, Motobe K, Yamashina A. Arterial stiffening as a possible risk factor for both atherosclerosis and diastolic heart failure. Hypertens Res 2004; 27:625-31.
44.Yamashina A, Tomiyama H, Takeda K, Tsuda T, Arai T, Hirose K, et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25:359-64.
45.Sato H, Hayashi J, Harashima K, Shimazu H, Kitamoto K. A population-based study of arterial stiffness index in relation to cardiovascular risk factors. J Atheroscler Thromb 2005;12:175-80.
46.Shiotani A, Motoyama M, Matsuda T, Miyanishi T. Brachial-ankle pulse wave velocity in Japanese university students. Int Med 2005;44:696-701.
47.Jae SY, Fernhall B, Heffernan KS, Kang M, Lee MK, Choi YH, Hong KP, Ahn ES, Park WH. Exaggerated blood pressure response to exercise is associated with carotid atherosclerosis in apparently healthy men. J Hypertens 2006;24:881-7.
48.Julius S. The evidence for pathophysiologic significants of the sympathetic overactivity in hypertension. Clin Exper Hypertension 1996;18:305-21.
49.Julius S. Interaction between rennin and the autonomic nervous system in hypertension. Am Heart J 1988;116:611-6.
50.Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability standards of measurement, physiological interpretation, and clinical use. Circulation 1996;93:1043-65.
51.陳高揚、郭正典、駱惠銘。心率變異度:原理與應用。 J Emerg Cric Care Med 2000;11:47-58.
52.Elghozi JL, Girard A, Laude D. Effects of drugs on the autonomic control of short-term heart rate variability. Autonomic Neuroscience: Basic and Clinical 2001;90:116-21.
53.Kuo TBJ, Lin Tsann, Yang CCH, Li CL, Chen CF, Chou P. Effect of aging on gender differences in neural control of heart rate. Am J Physiol 1999: H2233-9.
54.Ruediger H, Seibt R, Scheuch K, Krause M, Alam S. Sympathetic and parasympathetic actiovation in heart rate variability in male hypertensive patients under mental stress. J Hum Hypertens 2004;18:307-15.
55.American College of Sports Medicine. ACSM’s guidelines for exercise testing and prescription. PA: Williams and Wilkins, 2006.
56.Cheng TA, William P. The design and development of a screening questionnaire (CHQ) for use in community studies of mental disorders in Taiwan. Psychological Medicine 1986;16:415-22.
57.Chong MY, Wilkinson G.. Validation of 30- and 12-item version of the Chinese health questionnaire (CHQ) in patients admitted for general health screening. Psychological Medicine 1989;19:495-505.
58.Cheng TA, Wu JT, Williams P. Internal consistency and factor structure of the Chinese health questionnaire. Acta Psychiatr Scand 1990;82:304-8.
59.Chen CS, Tsang HY, Chong MY, Tang TC. Validation of the Chinese health questionnaire (CHQ-12) in community elders. Kaohsiung J Med 2000; 16:559-65.
60.Sallis JF, Haskell WL, Wood PD, Fortmann SP, Rogers T, Blair SN, et al. Physical activity assessment methodology in Five-City Project. Am J Epidemiol 1985;121:91-106.
61.Chien MY, Wu YT, Kwan WK, Chien CL. Reliability of the Chinese version of the 7-day recall physical activity questionnaire and its correlation with impairment of disease and function. FJPT 2003;28:1-8.
62.Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
63.Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 1992;40:922-35.
64.Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
65.行政院衛生署國民健康局,代謝症候群臨床診斷準則,2004。
66.Anonymous WG. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel Ⅲ). JAMA 2001;285:2486-97.
67.Chuang SY, Chen CH, Tsai ST, Chou P. Clinical identification of the metabolic syndrome in Kinmen. Acta Cardiol Sin 2002;18:16-23.
68.Cooper CB, Storer TW. Response variables. In: Cooper CB, Storer TW, editors. Exercise testing and interpretation: a practical approach. United Kingdom: Cambridge University Press; 2001. p.93-148
69.Fazio S, Palmieri EA, Izzo R, Affuso F, Romano M, Riccio G, et al. An exaggerated systolic blood pressure response to exercise is associated with cardiovascular remodeling in subjects with prehypertension. Ital Heart J 2005;6:886-92.
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top